Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial-Reference-Cited by-同舟云学术

Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial

Published:2011-06 Issue:8-9 Volume:18 Page:739-742
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Singer A.,Schmidt M.,Hauke W.,Stade K.

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference33 articles.

1. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV);American Psychiatric Association (APA),1994

2. Preventing recurrent depression: long-term treatment for major depressive disorder;Blier;J. Clin. Psychiatry,2007

3. Depressive illness;Doris;Lancet,1999

4. EMEA, 2002. Note for guidance on clinical investigation of medicinal products in the treatment of depression. CPMP/EWP/518/97 rev1.

5. Antidepressants and psychotherapy: a clinical research review;Frank;Dialogues Clin. Neurosci.,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments;Frontiers in Pharmacology;2023-09-28

2. Adaptogens on Depression-Related Outcomes: A Systematic Integrative Review and Rationale of Synergism with Physical Activity;International Journal of Environmental Research and Public Health;2023-03-28

3. The efficacy and safety of St. John’s wort extract in depression therapy compared to SSRIs in adults: A meta-analysis of randomized clinical trials;Advances in Clinical and Experimental Medicine;2022-10-11

4. Hypericum perforatum: Traditional uses, clinical trials, and drug interactions;IRAN J BASIC MED SCI;2022

5. Potential Mechanisms of Shu Gan Jie Yu Capsule in the Treatment of Mild to Moderate Depression Based on Systemic Pharmacology and Current Evidence;Evidence-Based Complementary and Alternative Medicine;2022-08-22